Breast Cancer Vaccine

By Sayantika Ghosh, Gaea News Network
Wednesday, June 2, 2010

Breast Cancer

PHILADELPHIA (GaeaTimes.com)- Breast cancer which happens to be one of the most dominant health issues might receive a vaccine for its prevention. Reportedly, Massimo Cristofanilli, who happens to be the chairman of Fox Chase Cancer Center, Philadelphia told the media that the experimental study of vaccine upon genetically engineered mice have turned out to be successful in prevention of breast cancer but it shall take time to confirm whether a similar treatment can be tried upon woman to save them from breast cancer.

Massimo Cristofanilli, further said that mice as a genetically engineered organism has always shown positive results but when it comes to humans things have gone just the opposite way. Moreover, even if the experiment turns out to be successful on humans, chances are very less that the proposed drug would get approved. As a matter of fact, The Pharmaceutical Research and Manufacturers of America approves 1 drug out of 250 proposed lab study drugs on an average. Cleveland Clinic’s Lerner Research Institute immunologist Vincent Tuohy have tested the vaccine against alpha-lactalbumin which happens to be a protein that resides on breast cancer cells. The mice thus used in the experiment was modified accordingly to suit the experimental conditions. It was said that 50 such genetically modified mice which received the vaccine showed no signs of breast cancer while other mice who were kept away from the vaccine developed breast cancer.

Massimo Cristofanilli says that such trials upon women involves risk. Besides there are other ways through which a woman can prevent herself from breast cancer. Breast cancer normally develops in those women who have genetic mutations in BRCA genes but an early stage mastectomy lessens the chance for the development of breast cancer.

Filed under: Featured Article, Health

Tags:
YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :